Food: An unrecognized source of loop diuretic resistance

被引:9
作者
Bard, RL
Bleske, BE
Nicklas, JM
机构
[1] Univ Michigan, Ctr Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Med, Coll Pharm, Ann Arbor, MI 48109 USA
来源
PHARMACOTHERAPY | 2004年 / 24卷 / 05期
关键词
loop diuretics; furosemide; bumetanide; torsemide; edema;
D O I
10.1592/phco.24.6.630.34736
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Food significantly affects the pharmacokinetics of oral loop diuretics in healthy individuals, but studies have not been performed in patients with edema. Because of this omission, food's effect on pharmacokinetics has been overlooked and may decrease the pharmacodynamic response in patients who rely on diuretics. Despite this potential interaction, reference manuals do not provide warnings about the effects of food on loop diuretic absorption. We reviewed the published human studies investigating the effects of food on loop diuretics. Peak plasma concentrations and urinary recovery were significantly decreased when taken with food, but only one study showed a corresponding decrease in total urine output, which is likely related to the diuretic threshold effect. These healthy subjects probably were always above the diuretic threshold under both fed and fasting conditions and thus could not augment their urine output. Based on these data in healthy subjects, the special implications for patients who routinely take diuretics are discussed. Therefore, food is more likely to have a clinical effect on the diuretic threshold given its effect in healthy subjects and the special considerations for patients with edema. Additional studies are needed to help answer these questions. Until such data are available, the most conservative, effective clinical approach is to administer oral loop diuretics without food.
引用
收藏
页码:630 / 637
页数:8
相关论文
共 26 条
[1]  
BARR WH, 1990, PR PHARM CL, V8, P15
[2]   REDUCED BIOAVAILABILITY AND EFFECT OF FUROSEMIDE GIVEN WITH FOOD [J].
BEERMANN, B ;
MIDSKOV, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) :725-727
[3]   PHARMACOKINETICS-PHARMACODYNAMICS OF FUROSEMIDE IN MAN - REVIEW [J].
BENET, LZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :1-27
[4]   PHARMACOKINETICS IN PATIENTS WITH CARDIAC-FAILURE [J].
BENOWITZ, NL ;
MEISTER, W .
CLINICAL PHARMACOKINETICS, 1976, 1 (06) :389-405
[5]   ABSORPTION AND DISPOSITION OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE [J].
BRATER, DC ;
SEIWELL, R ;
ANDERSON, S ;
BURDETTE, A ;
DEHMER, GJ ;
CHENNAVASIN, P .
KIDNEY INTERNATIONAL, 1982, 22 (02) :171-176
[6]   FUROSEMIDE IN PATIENTS WITH HEART-FAILURE - SHIFT IN DOSE-RESPONSE CURVES [J].
BRATER, DC ;
CHENNAVASIN, P ;
SEIWELL, R ;
BECK, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :182-186
[7]   RESISTANCE TO LOOP DIURETICS - WHY IT HAPPENS AND WHAT TO DO ABOUT IT [J].
BRATER, DC .
DRUGS, 1985, 30 (05) :427-443
[8]   BUMETANIDE AND FUROSEMIDE IN HEART-FAILURE [J].
BRATER, DC ;
DAY, B ;
BURDETTE, A ;
ANDERSON, S .
KIDNEY INTERNATIONAL, 1984, 26 (02) :183-189
[9]   PHARMACOKINETICS OF FUROSEMIDE IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
GREITHER, A ;
GOLDMAN, S ;
EDELEN, JS ;
BENET, LZ ;
COHN, K .
PHARMACOLOGY, 1979, 19 (03) :121-131
[10]  
HAMMARLUND MM, 1985, J PHARMACOL EXP THER, V233, P447